Literature DB >> 1733827

Birth and population prevalence of Duchenne muscular dystrophy in The Netherlands.

A J van Essen1, H F Busch, G J te Meerman, L P ten Kate.   

Abstract

Mutations causing Duchenne muscular dystrophy (DMD) have a short survival. Therefore, birth and population prevalence are maintained by new mutations. The present inventory was made to estimate the birth and population prevalence rates of DMD in the Netherlands. Seven methods of case identification were used. Data on 496 definite, probable or possible DMD patients born since 1961, or alive on January 1, 1983, were obtained. Several methods gave an estimated ascertainment of more than 95%. The prevalence rate at birth of DMD was estimated at 23.7 x 10(-5) (1:4215) male live births (MLB) yearly. The prevalence rate in the male population on January 1, 1983 was 5.4 x 10(-5) (1:18496). About 1% of the males in this study may have autosomal recessive Duchenne-like muscular dystrophy. Until now there has been no convincing evidence for geographic differences in DMD prevalence at birth. A list of frequency studies of Duchenne muscular dystrophy is included. The DMD mutation rate calculated by the indirect method is 7.9 x 10(-5) genes per generation. However, this may well be an over-estimate, as this method does not account for germline mosaicism. Using a modified sex ratio method the proportion of sporadic DMD among all cases was estimated to be 0.106 (range 0-0.332). High frequency of germline mosaicism in DMD is a likely cause for the apparent lack of sporadic cases as found in previous studies, if mutation rates in male and female gametes are equal. Therefore, methods for estimating the proportion of new mutants in DMD should take germline mosaicism into account. The modified sex ratio method allows incorporation of data on germline mosaicism if available.

Entities:  

Mesh:

Year:  1992        PMID: 1733827     DOI: 10.1007/bf00197256

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  53 in total

1.  [PROGRESSIVE MUSCULAR DYSTROPHY. VI. INCIDENCE, CLINICAL ASPECTS AND GENETICS OF THE DUCHENNE TYPE].

Authors:  H MOSER; U WIESMANN; R RICHTERICH; E ROSSI
Journal:  Schweiz Med Wochenschr       Date:  1964-11-14

2.  Germinal mosaicism increases the recurrence risk for 'new' Duchenne muscular dystrophy mutations.

Authors:  E Bakker; H Veenema; J T Den Dunnen; C van Broeckhoven; P M Grootscholten; E J Bonten; G J van Ommen; P L Pearson
Journal:  J Med Genet       Date:  1989-09       Impact factor: 6.318

3.  Sex ratio of the mutation frequencies in haemophilia A: coagulation assays and RFLP analysis.

Authors:  A H Bröcker-Vriends; F R Rosendaal; J C van Houwelingen; E Bakker; G J van Ommen; J J van de Kamp; E Briët
Journal:  J Med Genet       Date:  1991-10       Impact factor: 6.318

4.  Studies in disorders of muscle. V. The inheritance of childhood progressive muscular dystrophy in 33 kindreds.

Authors:  F E STEPHENS; F H TYLER
Journal:  Am J Hum Genet       Date:  1951-06       Impact factor: 11.025

5.  Genetic-epidemiological studies in progressive muscular dystrophy.

Authors:  J Prot
Journal:  J Med Genet       Date:  1971-03       Impact factor: 6.318

6.  The incidence of Duchenne muscular dystrophy in the South East of Scotland.

Authors:  A P Brooks; A E Emery
Journal:  Clin Genet       Date:  1977-04       Impact factor: 4.438

7.  A genetic study of Duchenne muscular dystrophy in West Midlands.

Authors:  S Bundey
Journal:  J Med Genet       Date:  1981-02       Impact factor: 6.318

8.  Genetic epidemiology of Duchenne muscular dystrophy in Japan: classical segregation analysis.

Authors:  M Kanamori; N E Morton; K Fujiki; K Kondo
Journal:  Genet Epidemiol       Date:  1987       Impact factor: 2.135

9.  Estimate of the proportion of Duchenne muscular dystrophy with autosomal recessive inheritance.

Authors:  M Zatz; M R Passos-Bueno; D Rapaport
Journal:  Am J Med Genet       Date:  1989-03

10.  Population data on benign and severe forms of X-linked muscular dystrophy.

Authors:  M L Mostacciuolo; A Lombardi; V Cambissa; G A Danieli; C Angelini
Journal:  Hum Genet       Date:  1987-03       Impact factor: 4.132

View more
  16 in total

1.  Simulations provide support for the common disease-common variant hypothesis.

Authors:  Bo Peng; Marek Kimmel
Journal:  Genetics       Date:  2006-12-06       Impact factor: 4.562

2.  Quantitative Magnetic Resonance Imaging of Skeletal Muscle Disease.

Authors:  Bruce M Damon; Ke Li; Richard D Dortch; E Brian Welch; Jane H Park; Amanda K W Buck; Theodore F Towse; Mark D Does; Daniel F Gochberg; Nathan D Bryant
Journal:  J Vis Exp       Date:  2016-12-18       Impact factor: 1.355

3.  Prevalence of Duchenne and Becker muscular dystrophies in the United States.

Authors:  Paul A Romitti; Yong Zhu; Soman Puzhankara; Katherine A James; Sarah K Nabukera; Gideon K D Zamba; Emma Ciafaloni; Christopher Cunniff; Charlotte M Druschel; Katherine D Mathews; Dennis J Matthews; F John Meaney; Jennifer G Andrews; Kristin M Caspers Conway; Deborah J Fox; Natalie Street; Melissa M Adams; Julie Bolen
Journal:  Pediatrics       Date:  2015-02-16       Impact factor: 7.124

4.  Physical training in boys with Duchenne Muscular Dystrophy: the protocol of the No Use is Disuse study.

Authors:  Merel Jansen; Imelda Jm de Groot; Nens van Alfen; Alexander Ch Geurts
Journal:  BMC Pediatr       Date:  2010-08-06       Impact factor: 2.125

5.  Gene diagnosis for nine Chinese patients with DMD/BMD by multiplex ligation-dependent probe amplification and prenatal diagnosis for one of them.

Authors:  Yupeng Wu; Gengxin Yin; Keqin Fu; De Wu; Qian Zhai; Huarong Du; Zhongjun Huang; Yuhua Niu
Journal:  J Clin Lab Anal       Date:  2009       Impact factor: 2.352

6.  On the origin of deletions and point mutations in Duchenne muscular dystrophy: most deletions arise in oogenesis and most point mutations result from events in spermatogenesis.

Authors:  T Grimm; G Meng; S Liechti-Gallati; T Bettecken; C R Müller; B Müller
Journal:  J Med Genet       Date:  1994-03       Impact factor: 6.318

7.  Accurate Quantitation of Dystrophin Protein in Human Skeletal Muscle Using Mass Spectrometry.

Authors:  Kristy J Brown; Ramya Marathi; Alyson A Fiorillo; Eugene F Ciccimaro; Seema Sharma; David S Rowlands; Sree Rayavarapu; Kanneboyina Nagaraju; Eric P Hoffman; Yetrib Hathout
Journal:  J Bioanal Biomed       Date:  2012-12-18

8.  Low human dystrophin levels prevent cardiac electrophysiological and structural remodelling in a Duchenne mouse model.

Authors:  Gerard A Marchal; Maaike van Putten; Arie O Verkerk; Simona Casini; Kayleigh Putker; Shirley C M van Amersfoorth; Annemieke Aartsma-Rus; Elisabeth M Lodder; Carol Ann Remme
Journal:  Sci Rep       Date:  2021-05-07       Impact factor: 4.379

9.  Automated DNA mutation detection using universal conditions direct sequencing: application to ten muscular dystrophy genes.

Authors:  Richard R Bennett; Hal E Schneider; Elicia Estrella; Stephanie Burgess; Andrew S Cheng; Caitlin Barrett; Va Lip; Poh San Lai; Yiping Shen; Bai-Lin Wu; Basil T Darras; Alan H Beggs; Louis M Kunkel
Journal:  BMC Genet       Date:  2009-10-18       Impact factor: 2.797

10.  Duchenne and Becker Muscular Dystrophies' Prevalence in MD STARnet Surveillance Sites: An Examination of Racial and Ethnic Differences.

Authors:  Yanan Zhang; Joshua R Mann; Katherine A James; Suzanne McDermott; Kristin M Conway; Pangaja Paramsothy; Tiffany Smith; Bo Cai
Journal:  Neuroepidemiology       Date:  2021-01-21       Impact factor: 3.282

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.